Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Country Snapshot - Canada
2.3. Country Analysis - Canada
2.4. Scope Of Study
2.5. Crisis Scenario Analysis
2.5.1. Impact Of Covid-19 On Ophthalmic Drugs Market
2.6. Major Market Findings
2.6.1. Emerging Therapies For Dry Eye Syndrome
2.6.2. Growing Demand For Combination Therapies
2.6.3. Increasing Investment In Research & Development
2.6.4. Shift Toward Over-The-Counter (Otc) Products

3. Market Dynamics
3.1. Key Drivers
3.1.1. Aging Population’S Susceptibility To Age-Related Eye Conditions
3.1.2. Advancements In Drug Delivery Technologies
3.1.3. Rising Prevalence Of Eye Diseases And Disorders
3.1.4. Favorable Reimbursement Policies By Healthcare Systems
3.2. Key Restraints
3.2.1. Delay In Drug Approvals
3.2.2. Side Effects Related To Ophthalmic Drugs

4. Key Analytics
4.1. Key Market Trends
4.1.1. Growing Interest In Topical Ophthalmic Drugs
4.1.2. Significant Rise In Novel Ophthalmic Therapeutics Approvals
4.2. Technology Snapshot
4.2.1. Biologics
4.2.2. Cell Therapy
4.2.3. Gene Therapy
4.2.4. Drug Delivery
4.2.5. Small Molecule
4.2.6. Other Technologies
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Growth Prospect Mapping - Canada
4.5. Market Maturity Analysis
4.6. Market Concentration Analysis
4.7. Key Buying Criteria
4.8. Regulatory Framework

5. Market By Indication
5.1. Dry Eye
5.2. Glaucoma
5.3. Infection/Inflammation/Allergies
5.4. Retinal Disorder
5.4.1. Wet Age-Related Macular Degeneration
5.4.2. Dry Age-Related Macular Degeneration
5.4.3. Diabetic Retinopathy
5.4.4. Other Retinal Disorders
5.5. Other Indications

6. Market By Type
6.1. Prescription Drugs
6.2. Over-The-Counter Drugs

7. Market By Dosage Form
7.1. Gels
7.2. Eye Solutions & Suspensions
7.3. Capsules & Tablets
7.4. Eye Drops
7.5. Ointments

8. Market By Therapeutic Class
8.1. Anti-Glaucoma
8.2. Anti-Infection
8.3. Anti-Inflammatory
8.4. Anti-Allergy
8.5. Other Therapeutic Classes

9. Market By Distribution Channel
9.1. Hospital Pharmacies
9.2. Drug Stores
9.3. Online Pharmacies
9.4. Other Distribution Channels

10. Competitive Landscape
10.1. Key Strategic Developments
10.1.1. Mergers & Acquisitions
10.1.2. Product Launches & Developments
10.1.3. Partnerships & Agreements
10.2. Company Profiles
10.2.1. Abbvie Inc
10.2.1.1. Company Overview
10.2.1.2. Products & Services
10.2.1.3. Strengths & Challenges
10.2.2. Bausch Health Companies Inc
10.2.2.1. Company Overview
10.2.2.2. Products & Services
10.2.2.3. Strengths & Challenges
10.2.3. Johnson & Johnson
10.2.3.1. Company Overview
10.2.3.2. Products & Services
10.2.3.3. Strengths & Challenges
10.2.4. Novartis Ag
10.2.4.1. Company Overview
10.2.4.2. Products & Services
10.2.4.3. Strengths & Challenges
10.2.5. Pfizer Inc
10.2.5.1. Company Overview
10.2.5.2. Products & Services
10.2.5.3. Strengths & Challenges
10.2.6. Regeneron Pharmaceuticals Inc
10.2.6.1. Company Overview
10.2.6.2. Products & Services
10.2.6.3. Strengths & Challenges
10.2.7. Santen Pharmaceutical Co Ltd
10.2.7.1. Company Overview
10.2.7.2. Products & Services
10.2.7.3. Strengths & Challenges



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Growth Prospect Mapping - Canada
Figure 4: Market Maturity Analysis
Figure 5: Market Concentration Analysis
Figure 6: Canada Ophthalmic Drugs Market, Growth Potential, By Indication, In 2022
Figure 7: Canada Ophthalmic Drugs Market, By Dry Eye, 2023-2030 (In $ Million)
Figure 8: Canada Ophthalmic Drugs Market, By Glaucoma, 2023-2030 (In $ Million)
Figure 9: Canada Ophthalmic Drugs Market, By Infection/Inflammation/Allergies, 2023-2030 (In $ Million)
Figure 10: Canada Ophthalmic Drugs Market, By Retinal Disorder, 2023-2030 (In $ Million)
Figure 11: Canada Ophthalmic Drugs Market, Growth Potential, By Retinal Disorder, In 2022
Figure 12: Canada Ophthalmic Drugs Market, By Wet Age-Related Macular Degeneration, 2023-2030 (In $ Million)
Figure 13: Canada Ophthalmic Drugs Market, By Dry Age-Related Macular Degeneration, 2023-2030 (In $ Million)
Figure 14: Canada Ophthalmic Drugs Market, By Diabetic Retinopathy, 2023-2030 (In $ Million)
Figure 15: Canada Ophthalmic Drugs Market, By Other Retinal Disorders, 2023-2030 (In $ Million)
Figure 16: Canada Ophthalmic Drugs Market, By Other Indications, 2023-2030 (In $ Million)
Figure 17: Canada Ophthalmic Drugs Market, Growth Potential, By Type, In 2022
Figure 18: Canada Ophthalmic Drugs Market, By Prescription Drugs, 2023-2030 (In $ Million)
Figure 19: Canada Ophthalmic Drugs Market, By Over-The-Counter Drugs, 2023-2030 (In $ Million)
Figure 20: Canada Ophthalmic Drugs Market, Growth Potential, By Dosage Form, In 2022
Figure 21: Canada Ophthalmic Drugs Market, By Gels, 2023-2030 (In $ Million)
Figure 22: Canada Ophthalmic Drugs Market, By Eye Solutions & Suspensions, 2023-2030 (In $ Million)
Figure 23: Canada Ophthalmic Drugs Market, By Capsules & Tablets, 2023-2030 (In $ Million)
Figure 24: Canada Ophthalmic Drugs Market, By Eye Drops, 2023-2030 (In $ Million)
Figure 25: Canada Ophthalmic Drugs Market, By Ointments, 2023-2030 (In $ Million)
Figure 26: Canada Ophthalmic Drugs Market, Growth Potential, By Therapeutic Class, In 2022
Figure 27: Canada Ophthalmic Drugs Market, By Anti-Glaucoma, 2023-2030 (In $ Million)
Figure 28: Canada Ophthalmic Drugs Market, By Anti-Infection, 2023-2030 (In $ Million)
Figure 29: Canada Ophthalmic Drugs Market, By Anti-Inflammatory, 2023-2030 (In $ Million)
Figure 30: Canada Ophthalmic Drugs Market, By Anti-Allergy, 2023-2030 (In $ Million)
Figure 31: Canada Ophthalmic Drugs Market, By Other Therapeutic Classes, 2023-2030 (In $ Million)
Figure 32: Canada Ophthalmic Drugs Market, Growth Potential, By Distribution Channel, In 2022
Figure 33: Canada Ophthalmic Drugs Market, By Hospital Pharmacies, 2023-2030 (In $ Million)
Figure 34: Canada Ophthalmic Drugs Market, By Drug Stores, 2023-2030 (In $ Million)
Figure 35: Canada Ophthalmic Drugs Market, By Online Pharmacies, 2023-2030 (In $ Million)
Figure 36: Canada Ophthalmic Drugs Market, By Other Distribution Channels, 2023-2030 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – OPHTHALMIC DRUGS
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: CANADA OPHTHALMIC DRUGS MARKET, BY INDICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 4: CANADA OPHTHALMIC DRUGS MARKET, BY INDICATION, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 5: CANADA OPHTHALMIC DRUGS MARKET, BY RETINAL DISORDER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 6: CANADA OPHTHALMIC DRUGS MARKET, BY RETINAL DISORDER, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 7: CANADA OPHTHALMIC DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 8: CANADA OPHTHALMIC DRUGS MARKET, BY TYPE, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 9: CANADA OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 10: CANADA OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 11: CANADA OPHTHALMIC DRUGS MARKET, BY THERAPEUTIC CLASS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 12: CANADA OPHTHALMIC DRUGS MARKET, BY THERAPEUTIC CLASS, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 13: CANADA OPHTHALMIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 14: CANADA OPHTHALMIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 15: LIST OF MERGERS & ACQUISITIONS
TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS